Advances in improving mammalian cells metabolism for recombinant protein production
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Background: The production of recombinant proteins for therapeutic use represents a great impact on the biotechnology industry. In this context, established mammalian cell lines, especially CHO cells, have become a standard system for the production of such proteins. Their ability to properly configure and excrete proteins in functional form is an enormous advantage which should be contrasted with their inherent technological limitations. These cell systems exhibit a metabolic behaviour associated with elevated cell proliferation which involves a high consumption of glucose and glutamine, resulting in the rapid depletion of these nutrients in the medium and the accumulation of ammonium and lactate. Both phenomena contribute to the limitation of cell growth, the triggering of apoptotic processes and the loss of quality of the recombinant protein. Results: In this review, the use of alternative substrates and genetic modifications (host cell engineering) are analyzed as tools to overcome those limitations. In general, the results obtained are promising. However, metabolic and physiological phenomena involved in CHO cells are still barely understood. Thus, most of publications are focused on specific modifications rather than giving a systemic perspective. Conclusions: A deeper insight in the integrated understanding of metabolism and cell mechanisms is required in order to define complementary strategies at these two levels, so providing effective means to control nutrients consumption, reduce by-products and increase process productivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032 · cited 1×
“The use of CHO cells has been favoured over other cell lines due to their ability to produce r-proteins with complex post-translational modifications (e.g., glycosylation), which are essential to biologic functionality and security (Wurm, 2004).”
BackgroundWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001 · cited 1×
“…mitochondrial glutamine and glutaminase, its overexpression being correlated with an increase in the lactate production generated by glutaminolysis (Wise et al. 2008; Gao et al. 2009). c-Myc is also a factor participating in the regulation of cell proliferation and apoptosis (Mulukutla et al.…”
BackgroundMolecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
Macheda, M. L., Rogers, S., & Best, J. D. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20166 · Cited by 1,229
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801 · cited 1×
“However, other cell lines such as NS0, baby hamster kidney (BHK) and human embryo kidney-293 (HEK-293) cells have also received regulatory approval for rprotein production on a commercial scale (Jayapal et al. 2007; Mohan et al. 2008; Kim et al. 2012).”
BackgroundChoosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma?
Jose, C., Bellance, N., & Rossignol, R. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.012 · Cited by 518
Expression systems for therapeutic glycoprotein production
Durocher, Y., & Butler, M. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.008 · Cited by 386 · cited 1×
“…mammalian cells have remained during the last 25 years as the main expression system for the commercial production of therapeutic proteins, as this system creates DOI: 10.2225/vol16-issue3-fulltext-2 2 efficient post-translational modifications on the r-proteins (Durocher and Butler, 2009).”
BackgroundInfluentialLao, M.-S., & Toth, D. (1997) · Biotechnology Progress · doi:10.1021/bp9602360 · Cited by 268
Metabolic control of recombinant protein N‐glycan processing in NS0 and CHO cells
Baker, K. N., Rendall, M. H., Hills, A. E., Hoare, M., Freedman, R. B., & James, D. C. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1051 · Cited by 184 · cited 1×
“…is observed when the UDP-GNAc extracellular level increases, without affecting the NeuAc content of the glycoprotein (Grammatikos et al. 1998; Baker et al. 2001), whereas high ammonium ion concentrations lead not only to an increase in glycosylation branching but also to a loss of NeuAc in…”
BackgroundBorys, M. C., Linzer, D. I. H., & Papoutsakis, E. T. (1993) · Nature Biotechnology · doi:10.1038/nbt0693-720 · Cited by 171
Cited by
Mattick, C. S., Landis, A. E., Allenby, B. R., & Genovese, N. J. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b01614 · Cited by 382
A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism
Hefzi, H., Ang, K. S., Hanscho, M., Bordbar, A., Ruckerbauer, D., Lakshmanan, M., Orellana, C. A., Baycin-Hizal, D., Huang, Y., Ley, D., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.020 · Cited by 255
Pereira, S., Kildegaard, H. F., & Andersen, M. R. (2018) · Biotechnology Journal · doi:10.1002/biot.201700499 · Cited by 214
“We suggest the reader examines a set of particularly excellent reviews and research papers [15, 16, 28, 38].”
BackgroundPérez-Rodriguez, S., Ramírez-Lira, M. D. J., Trujillo-Roldán, M. A., & Valdez-Cruz, N. A. (2020) · Bioengineered · doi:10.1080/21655979.2020.1744266 · Cited by 32
Testing Lab-on-a-Chip Technology for Culturing Human Melanoma Cells under Simulated Microgravity
Przystupski, D., Górska, A., Michel, O., Podwin, A., Śniadek, P., Łapczyński, R., Saczko, J., & Kulbacka, J. (2021) · Cancers · doi:10.3390/cancers13030402 · Cited by 29
Metadata
- Authors
- Altamirano, C., Berrios, J., Vergara, M., & Becerra, S.
- Venue
- Electronic Journal of Biotechnology
- Publisher
- Elsevier BV
- Published
- 2013-05-15
- Volume
- 16
- Issue
- 3
- ISSN
- 0717-3458 (ISSN-L)
- OpenAlex
- W1969130234
- Cited by
- 60
- References
- 15
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in improving mammalian cells metabolism for recombinant protein production. https://app.cochat.ai/papers/10.2225/vol16-issue3-fulltext-2
- The paper
- Altamirano, C., Berrios, J., Vergara, M., & Becerra, S. (2013). Advances in improving mammalian cells metabolism for recombinant protein production. Electronic Journal of Biotechnology. https://doi.org/10.2225/vol16-issue3-fulltext-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.